Novo Nordisk CEO says food execs are ‘scared' of weight loss drug threat

Novo Nordisk CEO Lars Fruergaard Jorgensen has been fielding calls from food company chief executives who have questions about the company's diabetes and weight-loss-related drugs. "They are scared about it," Jorgensen told Bloomberg. The company confirmed to FOX Business he did not name names. However, it is no surprise that these drugs – Ozempic and Wegovy – which are the same medication but have different FDA-approved intended uses and are known to suppress appetites and change food preferences – are cat ...